Home Ingredients GOS (Galacto-Oligosaccharides)
Gut Health

GOS (Galacto-Oligosaccharides)

Evidence Level
Strong
2 Clinical Trials
6 Documented Benefits
4/5 Evidence Score

Galacto-oligosaccharides (GOS) are prebiotic fibers consisting of 2-8 galactose units with terminal glucose — produced enzymatically from lactose. Found naturally in human breast milk (as part of HMOs — human milk oligosaccharides, complex fingerprint), and in small amounts in some legumes. Commercially produced from cow's milk lactose using β-galactosidase. Distinguished as more bifidogenic than FOS in some studies, particularly for infant microbiome applications (basis for inclusion in many infant formulas).

Studied Dose 2.5-15 g/day; clinical research often 5-10 g/day; infant formula fortification 0.4-0.8 g per 100 mL
Active Compound Galacto-oligosaccharides (mixed DP 2-8; β(1-4) and β(1-6) galactose linkages with terminal glucose)

Benefits

Strong Bifidogenic Effect (Infant and Adult)

Multiple human trials show GOS strongly stimulates Bifidobacterium growth — comparable to or exceeding FOS in some studies. Particularly important in infant microbiome (mimics function of human milk oligosaccharides). Foundational mechanism.

Supported by Trial 1

Infant Formula Fortification (Standard Component)

Most modern infant formulas include GOS (often combined with FOS in 9:1 GOS:FOS ratio — Moro 2002 Vandenplas formulation) to mimic some prebiotic effects of human milk oligosaccharides (HMOs). Supports formula-fed infant microbiome development. Reduces formula constipation.

Supported by Trial 1

Constipation Relief

Multiple trials show GOS improves stool frequency, consistency in chronic constipation. Effects via osmotic and microbiome mechanisms. Useful for both adults and children.

Supported by Trial 1

Travelers' Diarrhea Prevention

trial showed GOS reduced incidence and severity of travelers' diarrhea. Mechanism: enhanced gut barrier function and pathogen exclusion.

Supported by Trial 2

Allergy / Atopy Prevention (Mixed Evidence)

Some trials in infants suggest GOS+FOS reduces atopic dermatitis incidence. Subsequent research mixed. Component of infant allergy prevention strategies.

Supported by Trial 1, Trial 2

Anxiety / Stress (Emerging)

trial showed GOS modestly reduced cortisol and improved attentional vigilance. Emerging gut-brain axis evidence.

Supported by Trial 2

Mechanism of action

1

Bifidobacterium-Selective Fermentation

GOS is preferentially fermented by Bifidobacterium species (particularly B. infantis, B. longum, B. breve). β-galactosidase activity in Bifidobacterium efficiently cleaves GOS. Result: significant Bifidobacterium expansion.

2

Mimics Human Milk Oligosaccharide Function

Human breast milk contains HMOs (human milk oligosaccharides) — complex fingerprint of ~200 different oligosaccharides supporting infant microbiome and immunity. GOS is structurally simpler than HMOs but provides some equivalent bifidogenic effect — basis for infant formula fortification.

3

Pathogen Exclusion / Decoy Receptor Effect

GOS may act as 'decoy receptors' that bind enteric pathogens — reducing pathogen attachment to intestinal epithelium. Mechanism for travelers' diarrhea protection and infection prevention effects.

4

SCFA Production (Same as FOS)

Fermentation produces acetate, propionate, butyrate; supports colonocyte health, gut barrier, immune function.

Clinical trials

1
GOS for Infant Microbiome

Trials of GOS+FOS (9:1) in infant formula vs standard formula on infant microbiome and constipation.

Formula-fed infants.

Significantly increased Bifidobacterium counts in stool, softer stools, higher stool frequency closer to breastfed pattern. Foundation for widespread infant formula fortification.

2
GOS for Travelers' Diarrhea

Clinical trial of GOS (5.5 g/day) vs placebo for travelers' diarrhea prevention in 159 healthy travelers.

159 travelers to high-risk destinations.

GOS group had reduced incidence and severity of travelers' diarrhea vs placebo. Established GOS as travel adjunct.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GAS, bloating (less than FOS in many people).
Abdominal discomfort at higher doses.
Diarrhea or loose stools at very high doses (osmotic).
Galactosemia — rare genetic disorder of galactose metabolism; avoid (life-threatening).
FODMAP component (lactose-derived) — IBS sensitivity in some.
Lactose contamination minor concern — most GOS products tested for low/no lactose.

Important Drug interactions

Generally minimal drug interactions.
Galactosemia — contraindicated.
Antibiotics — GOS supports microbiome recovery.
Diabetes medications — minimal interactions.
Pregnancy/lactation — generally safe; widely used in food and infant formulas.
Lactose intolerance — GOS production may leave trace lactose; commercial products typically tested low; severe lactose intolerance verify product.

Featured in these supplement guides

Constipation→

More Gut Health Ingredients

Gut Health
Pancrelipase / Pancreatin
Pancrelipase (also called pancreatin) is a standardized blend of three primary pancreatic…
Gut Health
Sunfiber® (Partially Hydrolyzed Guar Gum)
Sunfiber® is the original and most extensively clinically-studied partially hydrolyzed gua…
Gut Health
Peppermint (Mentha × piperita)
Peppermint is a hybrid mint (Mentha aquatica × Mentha spicata) whose leaves and extracted…
Gut Health
PepZinGI® (Zinc-Carnosine for Gut Lining)
PepZinGI® (NutriScience Innovations) is a unique chelate of zinc and L-carnosine in a 1:1…

Explore Other Ingredients

Cognitive
Citicoline
Citicoline (CDP-choline) is a naturally-occurring intermediate in phosphatidylcholine bios…
Cognitive
Phosphatidylserine
Phosphatidylserine (PS) is a phospholipid concentrated in neuronal cell membranes (10-20%…
Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb traditionally used in cold northern regions to comba…

Frequently asked questions about GOS (Galacto-Oligosaccharides)

What is GOS (galactooligosaccharides)?

GOS are prebiotic fibers derived from lactose (milk sugar), naturally present in human breast milk. They resist digestion and feed beneficial gut bacteria, especially bifidobacteria, supporting gut and immune health.

What is GOS used for?

GOS is used as a prebiotic to support a healthy microbiome, digestion, and immune function. Because it mimics fibers in breast milk, it is added to some infant formulas, and it is studied for gut and even stress-related support in adults.

Does GOS cause digestive issues?

Like other prebiotics, GOS can cause gas or bloating at higher amounts due to fermentation, though some people tolerate it better than FOS or inulin. Start low and increase gradually. It is a FODMAP for sensitive individuals.

Is GOS safe?

GOS is safe and beneficial for most people, including in infant nutrition. Digestive tolerance is the main limit, so those with IBS or FODMAP sensitivity should introduce it slowly.

What is GOS?

Galacto-oligosaccharides (GOS) are prebiotic fibers consisting of 2-8 galactose units with terminal glucose — produced enzymatically from lactose. Found naturally in human breast milk (as part of HMOs — human milk oligosaccharides, complex fingerprint), and in small amounts in some legumes.

What is the recommended dosage of GOS?

The clinically studied dose is 2.5-15 g/day; clinical research often 5-10 g/day; infant formula fortification 0.4-0.8 g per 100 mL Always follow the product label and check with a healthcare provider for personal advice.

Is GOS safe, and does it have side effects?

For most healthy adults, GOS is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GAS, bloating (less than FOS in many people). It may also interact with some medications. GOS is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does GOS interact with any medications?

Possible interactions include: Generally minimal drug interactions. Galactosemia — contraindicated. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for GOS?

NutraSmarts rates the evidence for GOS as Strong (4 out of 5). It is backed by 2 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Davis LM, Martinez I, Walter J, Hutkins R A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults Int J Food Microbiol. 2010;144(2):285-92. doi: 10.1016/j.ijfoodmicro.2010.10.007.PubMedUsed to support: Backs the bifidogenic prebiotic claim: GOS increased fecal bifidobacteria in healthy adults in a dose-dependent manner. Honesty: this is a microbiota-shift study (surrogate endpoint), not a clinical health-outcome trial, and higher doses drive more GI gas.
  2. Canfora EE, van der Beek CM, Hermes GDA, Goossens GH, Jocken JWE, Holst JJ, et al. Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals Gastroenterology. 2017;153(1):87-97.e3. doi: 10.1053/j.gastro.2017.03.051.PubMedUsed to support: Backs the bifidogenic claim while supplying the honest counterpoint: a 12-week RCT in obese prediabetic adults found GOS significantly increased fecal bifidobacteria but did not improve insulin sensitivity, body composition, or other metabolic markers. Honesty: the microbiome shift is real, but it did not translate into a metabolic benefit.
  3. Ben XM, Li J, Feng ZT, Shi SY, Lu YD, Chen R, Zhou XY Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli World J Gastroenterol. 2008;14(42):6564-8. doi: 10.3748/wjg.14.6564.PubMedUsed to support: Backs the bifidogenic prebiotic claim in the infant-formula context: adding GOS to formula increased intestinal Bifidobacteria and Lactobacilli toward a breast-fed-like profile. Honesty: a surrogate microbiota endpoint (not a clinical outcome), in infants, with a small sample.
  4. Whisner CM, Martin BR, Schoterman MH, Nakatsu CH, McCabe LD, McCabe GP, Wastney ME, van den Heuvel EG Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial Br J Nutr. 2013;110(7):1292-303. doi: 10.1017/S000711451300055X.PubMedUsed to support: Backs the calcium-absorption claim: 5 g/day GOS increased fractional calcium absorption and fecal bifidobacteria in adolescent girls. Honesty: effect on absorption was not strictly dose-proportional, the sample was small, and a downstream bone-mass benefit was inferred, not directly measured.